Thus, if the antitumor effects of MARCKS are dependent on its ability to interact with PI(4,5)P2, CRC cells with hyperphosphorylated (inactive) MARCKS should behave like CRC cells with absent MARCKS. The gene discussed is MARCKS; the disease is colorectal carcinoma.